Korro
IPOEditing RNA to rewrite the future of medicine
Public · Cambridge, United States · Founded 2019 · $271.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- korrobio.com
- Total Funding
- $271.0M
- Last Round
- $85.0M Private EquityMar 2026
- Rounds
- 4
- Type
- Public
About
Korro Bio is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing a new class of genetic medicines based on editing RNA. By leveraging endogenous RNA editing mechanisms, Korro's platform enables treatment of both rare and highly prevalent diseases. The company's lead program KRRO-110 targets alpha-1 antitrypsin deficiency (AATD). Founded in 2019 out of Atlas Venture, Korro merged with Frequency Therapeutics in 2023 and listed on Nasdaq (KRRO).
Summary
Korro is a Biotech company based in Cambridge, United States, founded in 2019. It has raised $271.0M in total across 4 rounds, most recently a $85.0M Private Equity round in Mar 2026. Investors include New Enterprise Associates, Atlas Venture and Venrock.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2026
Sign up to see all 4 rounds
Venture Round through Private Equity — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/korro"><img src="https://indexed.vc/api/badge/company/korro" alt="Korro on Indexed.vc" width="260" height="76" /></a>